MX348957B - Derivados de imidazol azabiciclicos sustituidos utiles como moduladores del receptor del canal 8 (subfamilia melastatina) del potencial de receptor transitorio. - Google Patents
Derivados de imidazol azabiciclicos sustituidos utiles como moduladores del receptor del canal 8 (subfamilia melastatina) del potencial de receptor transitorio.Info
- Publication number
- MX348957B MX348957B MX2016000495A MX2016000495A MX348957B MX 348957 B MX348957 B MX 348957B MX 2016000495 A MX2016000495 A MX 2016000495A MX 2016000495 A MX2016000495 A MX 2016000495A MX 348957 B MX348957 B MX 348957B
- Authority
- MX
- Mexico
- Prior art keywords
- inflammatory
- imidazole derivatives
- receptor modulators
- derivatives useful
- substituted aza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/16—Halogenated acetic acids
- C07C53/18—Halogenated acetic acids containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención está dirigida a derivados azabicíclicos sustituidos de imidazol, composiciones farmacéuticas que los contienen y su uso en el tratamiento de trastornos y condiciones modulados por el TRP M8, que incluyen, por ejemplo, dolor inflamatorio, hiperalgesia inflamatoria, condición de hipersensibilidad inflamatoria, dolor neuropático, alodinia neuropática al frío, hiperalgesia inflamatoria somática, hiperalgesia inflamatoria visceral, enfermedad cardiovascular agravada por el frío y enfermedad pulmonar agravada por el frío.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31087010P | 2010-03-05 | 2010-03-05 | |
PCT/US2011/026974 WO2011109587A1 (en) | 2010-03-05 | 2011-03-03 | Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
MX348957B true MX348957B (es) | 2017-07-04 |
Family
ID=43875233
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015000028A MX336354B (es) | 2010-03-05 | 2011-03-03 | Derivados de imidazol azabiciclicos sustituidos utiles como moduladores del receptor del canal 8 (subfamilia melastatina) del potencial de receptor transitorio. |
MX2016000495A MX348957B (es) | 2010-03-05 | 2011-03-03 | Derivados de imidazol azabiciclicos sustituidos utiles como moduladores del receptor del canal 8 (subfamilia melastatina) del potencial de receptor transitorio. |
MX2012010270A MX2012010270A (es) | 2010-03-05 | 2011-03-03 | Derivados de imidazol azabicíclicos sustituidos útiles como moduladores del receptor del canal 8 (subfamilia melastatina) del potencial de receptor transitorio. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015000028A MX336354B (es) | 2010-03-05 | 2011-03-03 | Derivados de imidazol azabiciclicos sustituidos utiles como moduladores del receptor del canal 8 (subfamilia melastatina) del potencial de receptor transitorio. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012010270A MX2012010270A (es) | 2010-03-05 | 2011-03-03 | Derivados de imidazol azabicíclicos sustituidos útiles como moduladores del receptor del canal 8 (subfamilia melastatina) del potencial de receptor transitorio. |
Country Status (16)
Country | Link |
---|---|
US (4) | US8680098B2 (es) |
EP (1) | EP2542552B1 (es) |
JP (1) | JP5782054B2 (es) |
KR (1) | KR101667277B1 (es) |
CN (1) | CN102884063B (es) |
AR (1) | AR080388A1 (es) |
AU (1) | AU2011223566B2 (es) |
BR (1) | BR112012022369A2 (es) |
CA (1) | CA2791715C (es) |
DK (1) | DK2542552T3 (es) |
ES (1) | ES2654399T3 (es) |
MX (3) | MX336354B (es) |
NZ (1) | NZ601998A (es) |
TW (1) | TWI567071B (es) |
UY (1) | UY33264A (es) |
WO (1) | WO2011109587A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8680098B2 (en) * | 2010-03-05 | 2014-03-25 | Janssen Pharmaceutica, Nv | Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
GB2539875B (en) | 2015-06-22 | 2017-09-20 | Time Machine Capital Ltd | Music Context System, Audio Track Structure and method of Real-Time Synchronization of Musical Content |
CN107709301B (zh) * | 2015-06-23 | 2021-06-22 | 橘生药品工业株式会社 | 吡唑衍生物或其药理学上可接受的盐 |
CN117088871A (zh) * | 2018-11-30 | 2023-11-21 | 四川科伦博泰生物医药股份有限公司 | 并环化合物、其制备方法及用途 |
CN110638807A (zh) * | 2019-08-23 | 2020-01-03 | 陈明英 | 局部镇痛用药物组合物、其制备方法及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60260579A (ja) | 1984-01-13 | 1985-12-23 | Yoshitomi Pharmaceut Ind Ltd | プリン誘導体 |
US20050033048A1 (en) * | 2000-12-12 | 2005-02-10 | Rajagopal Bakthavatchalam | Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
AU2002349477A1 (en) | 2001-11-26 | 2003-06-10 | Takeda Chemical Industries, Ltd. | Bicyclic derivative, process for producing the same, and use |
US7582761B2 (en) | 2002-10-17 | 2009-09-01 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
JP2007513105A (ja) * | 2003-12-02 | 2007-05-24 | ユ セ ベ ソシエテ アノニム | イミダゾール誘導体、その製法及び使用 |
AR050630A1 (es) * | 2004-09-09 | 2006-11-08 | Solvay Pharm Bv | DERIVADOS DE 6- TRIFLUOROMETIL PURINA 2- SUSTITUIDA CON ACTIVIDAD ANTAGONISTA DE ADENOSINA-A3. PROCESOS DE OBTENCIoN Y COMPOSICIONES FARMACÉUTICAS. |
GB0508472D0 (en) * | 2005-04-26 | 2005-06-01 | Glaxo Group Ltd | Compounds |
EP1891048A1 (en) | 2005-06-11 | 2008-02-27 | Vernalis (R&D) Limited | Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders |
AU2007228887B2 (en) | 2006-03-22 | 2012-02-02 | F. Hoffmann-La Roche Ag | Pyrazoles as 11-beta-HSD-1 |
US20080139608A1 (en) | 2006-12-06 | 2008-06-12 | Universiteit Leiden | 2,6,8, Trisubstituted 1-deazapurines and their different uses |
AU2008253311A1 (en) | 2007-05-18 | 2008-11-27 | Bayer Schering Pharma Aktiengesellshaft | Inhibitors of hypoxia inducible factor (HIF) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
NZ586872A (en) | 2008-02-06 | 2012-03-30 | Astrazeneca Ab | Spirocyclic amide compounds |
CN105622580B (zh) | 2008-04-28 | 2019-06-21 | 詹森药业有限公司 | 作为脯氨酰羟化酶抑制剂的苯并咪唑 |
US8680098B2 (en) * | 2010-03-05 | 2014-03-25 | Janssen Pharmaceutica, Nv | Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
-
2011
- 2011-02-25 US US13/034,922 patent/US8680098B2/en active Active
- 2011-03-03 ES ES11709244.5T patent/ES2654399T3/es active Active
- 2011-03-03 KR KR1020127025999A patent/KR101667277B1/ko active IP Right Grant
- 2011-03-03 JP JP2012556235A patent/JP5782054B2/ja not_active Expired - Fee Related
- 2011-03-03 MX MX2015000028A patent/MX336354B/es unknown
- 2011-03-03 MX MX2016000495A patent/MX348957B/es unknown
- 2011-03-03 NZ NZ601998A patent/NZ601998A/en not_active IP Right Cessation
- 2011-03-03 WO PCT/US2011/026974 patent/WO2011109587A1/en active Application Filing
- 2011-03-03 AU AU2011223566A patent/AU2011223566B2/en not_active Ceased
- 2011-03-03 EP EP11709244.5A patent/EP2542552B1/en active Active
- 2011-03-03 CN CN201180022551.2A patent/CN102884063B/zh not_active Expired - Fee Related
- 2011-03-03 CA CA2791715A patent/CA2791715C/en active Active
- 2011-03-03 MX MX2012010270A patent/MX2012010270A/es active IP Right Grant
- 2011-03-03 BR BR112012022369A patent/BR112012022369A2/pt not_active Application Discontinuation
- 2011-03-03 DK DK11709244.5T patent/DK2542552T3/en active
- 2011-03-04 TW TW100107247A patent/TWI567071B/zh not_active IP Right Cessation
- 2011-03-09 AR ARP110100720A patent/AR080388A1/es unknown
- 2011-03-09 UY UY0001033264A patent/UY33264A/es unknown
-
2014
- 2014-02-04 US US14/172,395 patent/US9023846B2/en active Active
-
2015
- 2015-02-17 US US14/623,671 patent/US9409915B2/en active Active
-
2016
- 2016-06-29 US US15/196,262 patent/US9718820B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20160304518A1 (en) | 2016-10-20 |
CA2791715A1 (en) | 2011-09-09 |
EP2542552B1 (en) | 2017-11-15 |
EP2542552A1 (en) | 2013-01-09 |
CN102884063A (zh) | 2013-01-16 |
US9718820B2 (en) | 2017-08-01 |
JP5782054B2 (ja) | 2015-09-24 |
US20140155395A1 (en) | 2014-06-05 |
ES2654399T3 (es) | 2018-02-13 |
JP2013521306A (ja) | 2013-06-10 |
UY33264A (es) | 2011-09-30 |
AU2011223566A1 (en) | 2012-09-20 |
US9023846B2 (en) | 2015-05-05 |
WO2011109587A1 (en) | 2011-09-09 |
US20150158875A1 (en) | 2015-06-11 |
MX336354B (es) | 2016-01-14 |
MX2012010270A (es) | 2013-04-24 |
AR080388A1 (es) | 2012-04-04 |
TW201144309A (en) | 2011-12-16 |
CN102884063B (zh) | 2015-11-25 |
KR20130018750A (ko) | 2013-02-25 |
CA2791715C (en) | 2018-05-15 |
US8680098B2 (en) | 2014-03-25 |
TWI567071B (zh) | 2017-01-21 |
NZ601998A (en) | 2014-03-28 |
AU2011223566B2 (en) | 2015-05-21 |
US20110218197A1 (en) | 2011-09-08 |
US9409915B2 (en) | 2016-08-09 |
DK2542552T3 (en) | 2017-12-11 |
BR112012022369A2 (pt) | 2017-08-29 |
KR101667277B1 (ko) | 2016-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20180103B1 (ar) | التركيب الصيدلاني للكاربيتوسين | |
MX351368B (es) | Compuestos heteroarilo y metodos para utilizarlos. | |
CA2871471C (en) | Dna-pk inhibitors | |
MY161088A (en) | Agonists of gpr40 | |
GEP20156266B (en) | Spiroheterocyclic n-oxypiperidines as pesticides | |
PH12014502141A1 (en) | New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists | |
WO2011082400A3 (en) | Modulators of immunoinhibitory receptor pd-1, and methods of use thereof | |
WO2008152099A3 (en) | Aryl/hetarylamides as modulators of the ep2 receptor | |
SG190785A1 (en) | Antiviral compounds | |
MX2018004357A (es) | Uso de pidiflumetofeno para la reduccion de contaminacion con micotoxinas en plantas. | |
NZ705213A (en) | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof | |
WO2012096929A3 (en) | Heteroaryl compounds and methods of use thereof | |
MY159059A (en) | 2-amino-4-arylthiazole compounds as trpa1 antagonists | |
EP2576578A4 (en) | POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF | |
MX2012012530A (es) | Derivados de n1-sulfonil-5-fluorpirimidinona. | |
MX348451B (es) | Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparación y su uso como antagonistas p2y12. | |
MX336354B (es) | Derivados de imidazol azabiciclicos sustituidos utiles como moduladores del receptor del canal 8 (subfamilia melastatina) del potencial de receptor transitorio. | |
WO2011123678A3 (en) | Substituted benzo-pyrido-triazolo-diazepine compounds | |
EA201490152A1 (ru) | Антагонисты trpm8 и их применение при лечении | |
MX2020006235A (es) | Nuevos derivados de benzamida como moduladores de ppar-gamma. | |
CA2818986A1 (en) | Indole derivatives as modulators of s1p receptors | |
WO2011151436A3 (en) | Azepin-derivatives as derivatives as g- protein coupled receptor (gpr43) agonists | |
IN2015DN00345A (es) | ||
WO2012061342A3 (en) | Substituted benzo-imidazo-pyrido-diazepine compounds | |
WO2011127482A3 (en) | Modulation of histone deacetylases for the treatment of metabolic disease, methods and compositions related thereto |